Clinical Study

Parameters of Blood Count and Tumor Markers in Patients with Borderline Ovarian Tumors: A Retrospective Analysis and Relation to Staging

Table 1

Laboratory parameters (mean ± standard deviation) in stage IA ( 𝑛 = 1 3 ) and IB-IIIC ( 𝑛 = 8 ) borderline ovarian tumors.

Stage IAStages IB-IIIC

Red blood cells ( × 1 0 6 /mm3) 4 . 7 8 ± 0 . 4 7 * 4 . 2 5 ± 0 . 5
Hematocrit (%) 4 1 . 9 ± 3 . 6 ** 3 6 . 9 1 ± 5 . 1 3
Haemoglobin (g/100 mL) 1 4 . 0 8 ± 1 . 3 *** 1 2 . 3 7 ± 1 . 9
Leucocytes (/mm3) 7 , 7 4 0 ± 2 , 6 0 7 . 1 8 , 1 6 2 . 5 ± 5 , 2 4 6 . 5
Platelets (/mm3) 2 5 9 , 0 7 6 . 9 2 ± 5 8 , 1 5 0 3 1 0 , 8 5 7 . 1 4 ± 8 8 , 4 9 4
Fasting glucose (mg/dL) 1 0 0 . 2 ± 2 5 . 9 3 1 0 4 . 5 ± 2 8 . 0 5
CA-125 (U/mL) 6 0 . 4 7 ± 1 3 2 . 8 6 4 . 3 4 ± 5 9 . 4 3
CA-15.3 (U/mL) 4 1 . 1 2 ± 5 3 . 5 5 2 8 . 8 5 ± 1 7 . 8 4
CA-19.9 (U/mL) 1 2 . 9 5 ± 1 3 . 8 2 3 . 8 4 ± 3 6 . 3 5
CEA (U/mL) 2 . 4 3 ± 3 . 7 9 . 8 6 ± 1 2 . 4 8
AFP (U/mL) 1 . 4 3 ± 0 . 6 5 1 . 4 2 ± 0 . 5 6

Unpaired 𝑡 -test. *,**,***respectively, 𝑃 < 0 . 0 3 , 0.01, 0.02, compared to stages IB-IIIC.